A detailed history of Apella Capital, LLC transactions in Omeros Corp stock. As of the latest transaction made, Apella Capital, LLC holds 14,288 shares of OMER stock, worth $147,309. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,288
Previous 14,288 -0.0%
Holding current value
$147,309
Previous $58,000 3.45%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Jan 18, 2022

BUY
$13.4 - $16.3 $191,459 - $232,894
14,288 New
14,288 $197,000
Q3 2021

Oct 12, 2021

SELL
$13.4 - $16.3 $191,459 - $232,894
-14,288 Closed
0 $0
Q2 2021

Jan 18, 2022

BUY
$14.81 - $19.13 $211,605 - $273,329
14,288 New
14,288 $212,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $647M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track Apella Capital, LLC Portfolio

Follow Apella Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apella Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apella Capital, LLC with notifications on news.